input parameter | baseline-value | SA/PSA | Source |
---|---|---|---|
cost inpatient surgery (DIS & ACLR) | 3,605.09€ | - | G-DRG catalogue |
cost DIS (Ligamys) | 1,284.00€ | - | Mathys AG, Bettlach |
cost monobloc removal (DIS) | 398.85 € | 2,190.83€ | Eggli et al. (2016) [33], expert opinion, G-DRG catalogue |
cost medical devices (ACLR) | 532.00€ | - | payer data |
average costs of rehab per cycle | 82.00€ | - | payer data |
cost medication (ACLR) | 117.92€ | - | official tariff (Lauer Taxe) |
cost medication (DIS) | 58.86€ | - | official tariff (Lauer Taxe) |
disutility for revision surgery | 0.05 | 0–0.1 | Mather et al. (2014) [6] |
monobloc removal rate (DIS) | 0.241 | 0.05 | Henle et al. (2015) [11] |
probability of revision surgery (DIS) | 0.029 | - | Henle et al. (2015) [11] |
probability of revision surgery (ACLR) | 0.025 | 0.0025–0.14 | Janssen et al. (2012); Magnussen et al. (2010); Lind et al. (2012); Frobell et al. (2013) [1, 4, 15, 31] |
days in hospital (DIS) | 2 | - | Henle et al. (2015) [11] |
days in hospital (ACLR) | 5 | - | Geiger et al. (2013) [25] |
discount rate | 0.03 | 0–0.05% | german HTA guidelines [26] |
number of prescriptions for rehab | 2 | - | payer data |
hrQoL baseline (DIS) | 0.85 | beta dist. 0.85 +/- 0.09 | study data on file |
hrQoL baseline (ACLR) | 0.80 | beta dist. 0.80 +/- 0.11 | Mather et al. (2014) [6] |
hrQoL first 12 m (DIS) | 0.79375 | beta dist. 0.79375 +/- 0.1 | study data on file |
hrQoL first 12 m (ACLR) | 0.79813 | beta dist. 0.79813 +/- 0.11 | Mather et al. (2014) [6] |
hrQoL after revision (DIS) | lq_ACLR_norm | Assumption; equals the baseline hrQoL of ACLR because ACLR treatment is the revision therapy for DIS | |
hrQoL after revision (ACLR) | 0.755 | 0.71–0.8 | Lind/Menhert et al. (2012); Spindler et al. (2011); Lind/Lund et al. (2012); Wright et al.(2011) [15, 17, 27, 30] |
time to revision surgery in months (ACLR) | 21.6 | 9.6–33.6 | Lind/Menhert et al. (2012) [15] |
time to revision surgery in months (DIS) | 11.1 | 3.5–24.3 | Henle et al. (2015) [11] |